Women Healthcare Market 2018 | Analysis by Top Players Revenue, Size, Share, Demand, Trends and Forecasts 2023

November 26, 2018

Originally published by Medgadget

This MRFR Market Perspective Examines the Historical Trends and Current Scenario of the “Global Women Healthcare Market” to Deliver a Highly Pertinent Growth Forecast. And Registering 5.04% CAGR Along with Top Companies and Mega Trends.

Global Women Healthcare Market Overview:

Women health is referred to the health problems that are specific to women anatomy. It relates to the unique issues which includes pregnancy, menopause, and conditions of the female organs. Women health also includes medical situations in which women face problems not directly related to their biology but due to gender-differentiated access to medical treatment. Women’s health issues have attained higher international perceptibility in the recent decades. The targeted policies and government initiatives to decrease the burden of the women health diseases have enabled women to lead healthier lives, while some significant gender-based health disparities remain in many countries. With limited awareness and less income levels in many developing countries are making health improvements for women exceptionally difficult.

The market for women healthcare is projected to grow at a steady CAGR of 5.04% during the forecast period from 2017-2023.

Get Exclusive Sample Report at https://www.marketresearchfuture.com/sample_request/3121

Market players of Global Women Healthcare Industry:

Market players of women healthcare industries are Allergan plc. (Ireland), Amgen (California), Bayer A G (Germany), Becton Dickinson and Company (U.S.), Eli Lilly Company (U.S.), Merck & Co., Inc., (U.S.), Pfizer Inc., (U.S.), and Teva Pharmaceuticals (Israel).

Segments:

The Women Healthcare Market is segmented on the basis of indications, diagnosis and treatment and also on the basis of end users. Based on the indications, the market has been segmented as postmenopausal osteoporosis, infertility, reproductive health management, polycystic ovary syndrome, gynecologic cancer and others. Gynecologic cancer segment has been further divided into breast, ovarian or other types of cancer. On the basis of diagnosis the market has been segmented as bone densitometry, diagnostic imaging tests, biopsies, ovulation testing and others. Similarly, on the basis of treatment the market has been classified as therapeutics, surgeries and others. Lastly on the basis of end users the market has been further classified into hospitals & clinics, gynecology centers, research institutes, and others.

Key Highlights:

With the growing awareness of early diagnosis, advanced treatment and growing novel drugs to treat the women health disorders among the patients and healthcare professionals has supported the growth of the market. The health of women is of particular concern as in many societies women are disadvantaged by discrimination rooted in sociocultural factors. For instance, women and girls face increased vulnerability to HIV/AIDS.

Globally, women healthcare market is dominated by several major players such as Allergan, Amgen, Bayer, BD, Eli Lily, Merck, Pfizer, Teva Pharmaceuticals and others. APAC region was the most benefited region due to the rising prevalence of the disease and rising number of treatment for women associated diseases and increasing advanced devices and therapeutics for gynecological disorders. The market for women healthcare is projected to grow at a steady CAGR of 5.04% during the forecast period from 2017-2023.

Regional analysis:

On the basis of region the market is segmented into North America, Europe, Asia-Pacific and Middle East and Africa. North America was commands the largest market share which is expected to reach USD 21,782.6 million by 2023 due to well-developed economy and initiatives taken to promote women healthcare in the region. On the other hand factors such as high cost of diagnosis and treatments are restricting the market growth in the Middle East & African region, while Asia-Pacific countries are expected to be the fastest growing region with a CAGR of 5.46% from 2017-2023.

Browse Complete 130 Pages Premium Research Report Enabled with 129 Respective Tables and Figures at https://www.marketresearchfuture.com/reports/women-healthcare-market-3121

Major TOC for Women Healthcare Market:

1 REPORT PROLOGUE

2 MARKET INTRODUCTION

2.1 INTRODUCTION

2.2 SCOPE OF STUDY

2.3 RESEARCH OBJECTIVE

2.4 ASSUMPTIONS & LIMITATIONS

2.4.1 ASSUMPTIONS

2.4.2 LIMITATIONS

2.5 MARKET STRUCTURE

3 RESEARCH METHODOLOGY

3.1 RESEARCH PROCESS

3.2 PRIMARY RESEARCH

3.3 SECONDARY RESEARCH

4 MARKET DYNAMICS

4.1 INTRODUCTION

4.2 DRIVERS

4.2.1 INCREASING POOR HEALTH CONDITIONS IS MAJOR CAUSE FOR FEMALE-SPECIFIC HEALTH ISSUES

4.2.2 GROWING EMPHASIS ON PREVENTIVE CARE SERVICES

4.2.3 INITIATIVES TAKEN TO PROMOTE WOMEN HEALTHCARE

4.2.4 INCREASE IN R&D ACTIVITIES BY MAJOR PLAYERS FOR WOMEN HEALTH

Read the full story at Medgadget